AMSTERDAM, July 8, 2013 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the launch of two new modules in Pure, Elsevier's research information management system. These modules are: Award Management and Research Intelligence.
Pure, one of the latest additions to Elsevier's SciVal research management tools, aggregates an institution's research and faculty information and provides customized reports for research administrators, researchers and librarians. The system facilitates an evidence-based approach to making business decisions, setting research strategy and performing assessment exercises.
With the Award Management module in Pure, users are now able to track funding opportunities, structure the grant application process and provide an overview of awarded grants and related projects. The Research Intelligence module complements this by allowing users to set departmental targets and display these and other customized metrics, such as Snowball Metrics, on dashboards that can be easily shared with members of their organization. Together these modules help Pure extend its coverage across the research management life cycle, enabling the entire institution to more successfully track and manage their research effectiveness.
"We've developed these modules in close collaboration with our European user groups, including more than 20 influential UK universities," says Thomas Jorgensen, Director of Product Management at Elsevier. "These capabilities will significantly simplify the usually arduous procedures of pre- and post award management and make the processes transparent. These enhancements will make our clients more efficient, and help guide them through the complex logistics of grant administration."
"Pure frees up time for the research administration office and helps the different departments throughout the research institution with the grant management process and record the successes of the research performed," said Nick Fowler, Elsevier's Managing Director of A&G Institutional Markets. "The institution and its departments will be in a position to provide more information around the impact of their research and thereby improve their prospects for future funding opportunities."
About Elsevier's SciVal suite
Designed to support the many stages of the research planning cycle, Elsevier's SciVal® suite of solutions provides information about research performance, funding and expertise to enable informed decision-making and drive successful outcomes. Serving research institutions, funding agencies and policy bodies, SciVal delivers objective analytical capabilities that can enhance the performance of individuals, teams and organizations. SciVal integrates institutional and external data sources with information from Elsevier's Scopus®, the standard for bibliometric research tools, to offer trusted solutions including SciVal Experts, SciVal Funding, SciVal Spotlight, SciVal Strata, SciVal Analytics and Pure. http://www.info.scival.com
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.